Thanks TDA,
Not quite the news we wanted, but there's our reason I guess.
I've no idea what happens with approved generics, but perhaps Apotex get a bit of promotion from the gsk reps with clients they suspect they will lose.
It looks like we need some more "phase 2 stunning results" data!
down she goes, page-8
Add TSN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| TSN (ASX) Chart |
Day chart unavailable